Saturday, December 3, 2022

DED Algorithm and Questionnaire: A Twin Support

Dear Dr. Renukaprasad A R,
Do preoperative diagnosis and treatment of dry eye disease (DED) or ocular surface disorder (OSD) help improve post-surgical outcomes?
DED can alter the outcomes of corneal, cataract, and refractive surgery, resulting in poor visual activity and postoperative patient satisfaction. Gaps in clinical proceedings, a lack of guidelines, and the complexities of OSD management have led the American Society of Cataract and Refractive Surgery (ASCRS) Cornea Clinical Committee to draft an OSD algorithm and questionnaire for the preoperative diagnosis and treatment of surgery candidates.
We bring you an exclusive article discussing the impact of preoperative DED diagnosis and treatment on post-surgical outcomes.

Highlights:
  • ASCRS OSD algorithm
  • ASCRS-modified Standard Patient Evaluation of Eye Dryness (SPEED) II questionnaire
  • COVID-19 and DED
  • Merits of OSD algorithm
  • Laser-assisted in situ keratomileusis (LASIK) surgery

Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India Reports Low Number of Covid Vaccine-related Adverse Events, & More

Docplexus is one of the world's largest online communities
Pune - 411045, India
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Friday, December 2, 2022

Does the Concentration of HA Matter in DED?

Dear Dr. Renukaprasad A R,
How important is the concentration of hyaluronic acid (HA) in DED treatment?

The corneal endothelium is coated with HA, an anionic glycosaminoglycan primarily present in connective tissue, vitreous humor, and aqueous humor. HA efficiently binds water, prevents dehydration, exhibits biocompatibility, stabilizes precorneal tear film, and enhances ocular surface irregularity. Therefore, HA plays a vital role as a lubricant component in treating DED.
Typical formulations still contain 0.1% HA, while higher concentration HA formulations are also presented.
Check out this infographic to know the detailed impact of the different concentrations of HA on DED.

Highlights:
  • Mechanism of action of HA in DED management
  • Pros and cons of eye drops with a high concentration of HA  
  • Study investigating the effect of low concentration, high concentration, and combination of HA eye drops for DED
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Thursday, December 1, 2022

Why are artificial tear products important for DED?

Dear Dr. Renukaprasad A R,
Inflammation, pain, and vision disruption are all ocular symptoms of dry eye disease (DED) that negatively influence patients' social and professional quality of life. Therefore, using artificial tear products (ATPs) is considered a potential therapy for DED, which can supplement or replace the natural tear film when it is inadequate. However, DED care depends on the severity of symptoms and indications.
Read this article, where we have summarized the most pertinent information about ATPs.
Key highlights:
  • ATPs used for dry eyes and their mechanism of action
  • Safety and efficacy of PEG-PG-HPG eye drops
  • Impact of environmental conditions on PEG-PG-HPG usage
  • The benefits of PEG-PG-HPG eye drops for contact lens wearers and the outcomes of cataract surgery
Abbreviations:
  1. PEG-PG-HPG: Polyethylene glycol- propylene glycol- hydroxypropyl guar.
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Wednesday, November 30, 2022

SMBG for Personalized Insulin Dose Management

Dear Dr. Renukaprasad A R,
Diabetes is the most common chronic condition worldwide. Comorbidity-associated risks and unique patient profiles demand a tailored treatment approach with constant monitoring of blood glucose levels for managing diabetes.
Diabetes management with insulin or glinides may have side effects in many patients, such as acute hypoglycemic episodes, damaging the central nervous system, causing dementia, or even fatality.1 Frequent blood glucose monitoring through self-monitoring blood glucose (SMBG) devices is necessary as it facilitates timely insulin dose adjustments.2
Read this case study depicting the importance of frequent blood glucose checks using the SMBG device and subsequent insulin dose adjustments to manage T2DM better.

References -
  1. Ceriello A et al., Diabetes research and clinical practice. 2012 Oct 1;98(1):5-10.
  2. Kalweit KL et al., Afr Med J [Internet]. 2018 [cited 2022 Nov 03];108(8):654-9.
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Recent Guidelines for AGC Management with Ramucirumab

Dear Dr. Renukaprasad A R,
Do you know the European Society for Medical Oncology (ESMO) has updated guidelines for advanced gastric cancer (AGC) diagnosis, treatment, and follow-up?

Globally, more than 1 million new cases of AGC were reported in 2020, resulting in 7,68,793 deaths. It is estimated that this burden will continue to rise due to the aging population and an increase in high-risk people.
Be a part of our exclusive session where renowned international and national oncology experts share the latest updates on guideline-based management, interesting clinical cases, and nutrition assessment and support for managing AGC.
Have you missed the Gastric Cancer Talks?

If you like to dive deep into some of the topics covered in the webinar, we have saved the recording just for YOU!


We hope you find this discussion helpful in your clinical practice.
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*